The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
A comprehensive catalogue of somatic mutations from a human cancer genome
Open accessAbstract
All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic. The two cancer genome sequences presented in this issue demonstrate how next-generation sequencing technologies can inform us about mutational processes, repair pathways and gene networks associated with cancer development. First, the genome of a cell line derived from a bone marrow metastasis in a patient who had small-cell lung cancer. This cancer is typical of the type induced by smoking, and the sequence contains mutation signatures characteristic of some of the more than 60 carcinogens present in tobacco smoke. The second paper compares the whole genome sequence of a melanoma cell line to a lymphoblastoid cell line from the same individual. This, the first complete mutational analysis of a solid tumour, reveals a dominant mutational signature reflecting DNA damage due to exposure to ultraviolet light. Here, the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person are sequenced, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The data provide insight into the causes of tumour formation and the development of the cancer genome, with the dominant mutational signature reflecting DNA damage due to ultraviolet light exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melanoma somatic mutations consist almost entirely of C → T transitions, 28% of which are TCC → T mutations (19,31).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Circos: An information aesthetic for comparative genomicsPreprint
Krzywinski, M. I., Schein, J. E., Birol, İ., Connors, J. M., Gascoyne, R. D., Horsman, D. E., Jones, S. J. M., & Marra, M. A. (2009) · Genome Research · doi:10.1101/gr.092759.109 · Cited by 11,029
Velvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Genome sequencing in microfabricated high-density picolitre reactors
Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., Berka, J., Braverman, M. S., Chen, Y.-J., Chen, Z., et al. (2005) · Nature · doi:10.1038/nature03959 · Cited by 7,693
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citationAccurate whole human genome sequencing using reversible terminator chemistry
Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., Smith, G. P., Milton, J., Brown, C. G., Hall, K. P., Evers, D. J., Barnes, C. L., Bignell, H. R., et al. (2008) · Nature · doi:10.1038/nature07517 · Cited by 3,684
Self-citationStratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationA census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Self-citation
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,001
Sobrinho-Simões, M. A., Eloy, C., Magalhães, J., Lobo, C., & Amaro, T. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.133 · Cited by 173
Computational approaches to identify functional genetic variants in cancer genomes
González-Pérez, A., López-Bigas, N., Mustonen, V., Ritchie, G. R. S., Butler, A. P., Dronov, S., Reva, B. A., Sander, C., Flicek, P., Creixell, P., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2562 · Cited by 176
Self-citationRoth, A. J. L., Ding, J., Morin, R. D., Crisan, A., Ha, G., Giuliany, R., Bashashati, A., Hirst, M., Turashvili, G., Oloumi, A., et al. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts053 · Cited by 173
Melanoma: Molecular Pathogenesis and Therapeutic Management.
Liu, Y., & Sheikh, M. S. (2014) · PubMed · Cited by 173
The genomic landscape of cutaneous melanoma
Zhang, T., Dutton‐Regester, K., Brown, K. M., & Hayward, N. K. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12459 · Cited by 182
ascatNgs: Identifying Somatically Acquired Copy‐Number Alterations from Whole‐Genome Sequencing Data
Raine, K. M., Loo, P. V., Wedge, D. C., Jones, D., Menzies, A. H., Butler, A. P., Teague, J. W., Tarpey, P. S., Nik‐Zainal, S., & Campbell, P. J. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.17 · Cited by 170
Self-citationTargeting epigenetics for cancer therapy
Park, J. W., & Han, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01126-z · Cited by 171
Unravelling UVA-induced mutagenesis
Sage, E., Girard, P.-M., & Francesconi, S. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05219e · Cited by 167
Sharpe, R., Pearson, A., Herrera-Abreu, M. T., Johnson, D., Mackay, A. G., Welti, J. C., Natrajan, R., Reynolds, A. R., Reis-Filho, J. S., Ashworth, A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2727 · Cited by 168
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma
Gartner, J. J., Parker, S. C. J., Prickett, T. D., Dutton‐Regester, K., Stitzel, M. L., Lin, J., Davis, S. R., Simhadri, V. L., Jha, S. S., Katagiri, N., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304227110 · Cited by 172
Analysis of the genome to personalize therapy for melanoma
Davies, M. A., & Samuels, Y. (2010) · Oncogene · doi:10.1038/onc.2010.323 · Cited by 190
Chronotherapy and the molecular clock: Clinical implications in oncology☆
Innominato, P. F., Lévi, F., & Bjarnason, G. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.06.002 · Cited by 168
Clonal evolution in hematological malignancies and therapeutic implications
Landau, D. A., Carter, S. L., Getz, G. A., & Wu, C. J. (2013) · Leukemia · doi:10.1038/leu.2013.248 · Cited by 173
Chromosomal landscape of UV damage formation and repair at single-nucleotide resolution
Mao, P., Smerdon, M. J., Roberts, S. A., & Wyrick, J. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606667113 · Cited by 167
A practical guide for mutational signature analysis in hematological malignancies
Maura, F., Degasperi, A., Nadeu, F., Leongamornlert, D., Davies, H., Moore, L., Royo, R., Ziccheddu, B., Puente, X. S., Avet-Loiseau, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11037-8 · Cited by 184
Self-citationComparison of somatic mutation calling methods in amplicon and whole exome sequence data
Xu, H., DiCarlo, J., Satya, R. V., Peng, Q., & Wang, Y. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-244 · Cited by 163
Melanoma metastasis: new concepts and evolving paradigms
Damsky, W., Theodosakis, N., & Bosenberg, M. (2013) · Oncogene · doi:10.1038/onc.2013.194 · Cited by 174
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma
Zhang, W., He, H., Zang, M., Wu, Q., Zhao, H., Lu, L.-L., Ma, P., Zheng, H., Wang, N.-J., Zhang, Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.024 · Cited by 169
Whole genome sequencing of matched primary and metastatic acral melanomasPreprint
Turajlic, S., Furney, S. J., Lambros, M. B. K., Mitsopoulos, C., Kozarewa, I., Geyer, F. C., Mackay, A. G., Hakas, J., Zvelebil, M., Lord, C. J., et al. (2011) · Genome Research · doi:10.1101/gr.125591.111 · Cited by 159
DNA replication fidelity and cancer
Preston, B. D., Albertson, T. M., & Herr, A. J. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.10.009 · Cited by 160
Rebecca, V. W., Sondak, V. K., & Smalley, K. S. M. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e328351fa4d · Cited by 176
Gusnanto, A., Wood, H. M., Yudi Pawitan, Y., Rabbitts, P. H., & Berri, S. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr593 · Cited by 163
Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL
Zaccaria, S., & Raphael, B. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0661-6 · Cited by 152
Reduced mutation rate in exons due to differential mismatch repair
Frigola, J., Sabarinathan, R., Mularoni, L., Muiños, F., González-Pérez, A., & López-Bigas, N. (2017) · Nature Genetics · doi:10.1038/ng.3991 · Cited by 161
Challenges of sequencing human genomes
Koboldt, D. C., Ding, L., Mardis, E. R., & Wilson, R. K. (2010) · Briefings in Bioinformatics · doi:10.1093/bib/bbq016 · Cited by 161
Acetaldehyde and the genome: Beyond nuclear DNA adducts and carcinogenesis
Brooks, P. J., & Zakhari, S. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21824 · Cited by 169
Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
Horak, P., Fröhling, S., & Glimm, H. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000094 · Cited by 162
Role of Reactive Oxygen Species in Aging and Age-Related Diseases: A Review
Anik, M. I., Mahmud, N., Masud, A. A., Khan, M. I., Islam, M. N., Uddin, S., & Hossain, M. K. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00411 · Cited by 163
Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors
Marçon, C. R., & Maia, M. (2019) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2019.09.023 · Cited by 153
Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers
Zhang, H., Liu, L., Zhang, J., Chen, J., Ye, J., Shukla, S. A., Qiao, J., Zhan, X., Chen, H., Wu, C. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3249 · Cited by 159
Shiina, T., Suzuki, S., Ozaki, Y., Taira, H., Kikkawa, E., Shigenari, A., Oka, A., Umemura, T., Joshita, S., Takahashi, O., et al. (2012) · Tissue Antigens · doi:10.1111/j.1399-0039.2012.01941.x · Cited by 152
Nucleotide excision repair: Why is it not used to predict response to platinum-based chemotherapy?
Bowden, N. A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.005 · Cited by 154
The roles of microphthalmia-associated transcription factor and pigmentation in melanoma
Hsiao, J. J., & Fisher, D. E. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.019 · Cited by 148
Opportunities and Challenges Associated with Clinical Diagnostic Genome Sequencing
Schrijver, I., Aziz, N., Farkas, D. H., Furtado, M. R., Gonzalez, A. F., Greiner, T. C., Grody, W. W., Hambuch, T. M., Kalman, L. V., Kant, J. A., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.04.006 · Cited by 150
Melanoma Epidemiology and Prevention
Berwick, M., Buller, D. B., Cust, A. E., Gallagher, R. P., Lee, T. K., Meyskens, F. L., Pandey, S., Thomas, N. E., Veierød, M. B., & Ward, S. V. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-22539-5_2 · Cited by 155
Immune and molecular correlates in melanoma treated with immune checkpoint blockade
Byrne, E. H., & Fisher, D. E. (2017) · Cancer · doi:10.1002/cncr.30444 · Cited by 157
Fleming, A. M., & Burrows, C. J. (2013) · Chemical Research in Toxicology · doi:10.1021/tx400028y · Cited by 149
Sensi, M., Catani, M., Castellano, G., Nicolini, G., Alciato, F., Tragni, G., Santis, G. D., Bersani, I., Avanzi, G., Tomassetti, A., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.218 · Cited by 148
The Conundrum of Genetic “Drivers” in Benign Conditions
Kato, S., Lippman, S. M., Flaherty, K. T., & Kurzrock, R. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw036 · Cited by 149
Interpreting the Dependence of Mutation Rates on Age and Time
Gao, Z., Wyman, M. J., Sella, G., & Przeworski, M. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002355 · Cited by 148
Analysis of next-generation genomic data in cancer: accomplishments and challenges
Ding, L., Wendl, M. C., Koboldt, D. C., & Mardis, E. R. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq391 · Cited by 148
Whole-genome reconstruction and mutational signatures in gastric cancer
Nagarajan, N., Bertrand, D., Hillmer, A. M., Zang, Z. J., Yao, F., Jacques, P., Teo, A. S. M., Cutcutache, I., Zhang, Z., Lee, W., et al. (2012) · Genome biology · doi:10.1186/gb-2012-13-12-r115 · Cited by 142
Existing and Emerging Technologies for Tumor Genomic Profiling
MacConaill, L. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5948 · Cited by 144
Functional Viability Profiles of Breast Cancer
Brough, R., Frankum, J. R., Sims, D., Mackay, A. G., Mendes‐Pereira, A. M., Bajrami, I., Costa-Cabral, S., Rafiq, R., Ahmad, A. S., Cerone, M. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0107 · Cited by 142
Cui, Y., Chen, X., Luo, H., Fan, Z., Luo, J., He, S., Yue, H., Zhang, P., & Chen, R. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw041 · Cited by 142
cgpPindel: Identifying Somatically Acquired Insertion and Deletion Events from Paired End Sequencing
Raine, K. M., Hinton, J., Butler, A. P., Teague, J. W., Davies, H. R., Tarpey, P. S., Nik‐Zainal, S., & Campbell, P. J. (2015) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi1507s52 · Cited by 134
Self-citationThompson, O., von Meyenn, F., Hewitt, Z., Alexander, J. J., Wood, A., Weightman, R., Gregory, S., Krueger, F., Andrews, S., Barbaric, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15271-3 · Cited by 135
Cheng, C., Zhou, Y., Li, H., Xiong, T., Li, S. C., Bi, Y., Kong, P., Wang, F., Cui, H., Li, Y., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.12.013 · Cited by 139
Personal genome sequencing: current approaches and challengesPreprint
Snyder, M. P., Du, J., & Gerstein, M. (2010) · Genes & Development · doi:10.1101/gad.1864110 · Cited by 145
Single nucleotide variations: Biological impact and theoretical interpretation
Katsonis, P., Koire, A. M., Wilson, S. J., Hsu, T., Lua, R. C., Wilkins, A. D., & Lichtarge, O. (2014) · Protein Science · doi:10.1002/pro.2552 · Cited by 145
Deep convolutional neural networks for accurate somatic mutation detection
Sahraeian, S. M. E., Liu, R., Lau, B., Podesta, K., Mohiyuddin, M., & Lam, H. Y. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09027-x · Cited by 137
An integrative probabilistic model for identification of structural variation in sequencing data
Sindi, S., Önal, S., Peng, L., Wu, H.-T., & Raphael, B. J. (2012) · Genome biology · doi:10.1186/gb-2012-13-3-r22 · Cited by 139
Abdel-Malek, Z. A., Kadekaro, A. L., & Swope, V. B. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00679.x · Cited by 134
Griffin, L. L., Ali, F. R., & Lear, J. T. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-1-62 · Cited by 134
Kamel, H. F. M., & Al-Amodi, H. S. A. B. (2017) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.11.005 · Cited by 137
Wong, K., Keane, T., Stalker, J. W., & Adams, D. J. (2010) · Genome biology · doi:10.1186/gb-2010-11-12-r128 · Cited by 135
Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma
Zhao, B., Zhao, S., SAID, J. W., Merino, M. J., Adeniran, A., Xie, Z., Nawaf, C., Choi, J., Belldegrun, A. S., Pantuck, A. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525735113 · Cited by 134
Melanoma: From Melanocyte to Genetic Alterations and Clinical Options
Bertolotto, C. (2013) · Scientifica · doi:10.1155/2013/635203 · Cited by 152
DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes
Woo, Y., & Li, W. (2012) · Nature Communications · doi:10.1038/ncomms1982 · Cited by 133
Insertions and Deletions Target Lineage-Defining Genes in Human Cancers
Imielinski, M. B., Guo, G., & Meyerson, M. M. (2017) · Cell · doi:10.1016/j.cell.2016.12.025 · Cited by 131
Garibyan, L., & Fisher, D. E. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0119-y · Cited by 132
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
Griewank, K., Schilling, B., Murali, R., Bielefeld, N., Schwamborn, M., Sucker, A., Zimmer, L., Hillen, U., Schaller, J., Brenn, T., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.168 · Cited by 128
Understanding mutagenesis through delineation of mutational signatures in human cancer
Petljak, M., & Alexandrov, L. B. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw055 · Cited by 110
Mutational landscape of yeast mutator strains
Serero, A., Jubin, C., Loeillet, S., Legoix-Né, P., & Nicolas, A. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314423111 · Cited by 126
Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair
Polak, P. P., Lawrence, M. S., Haugen, E., Stoletzki, N., Stojanov, P., Thurman, R. E., Garraway, L. A., Mirkin, S. M., Getz, G. A., Stamatoyannopoulos, J. A., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2778 · Cited by 132
Germline MC1R status influences somatic mutation burden in melanoma
Robles-Espinoza, C. D., Roberts, N. D., Chen, S., Leacy, F. P., Alexandrov, L. B., Pornputtapong, N., Halaban, R., Krauthammer, M., Cui, R., Timothy Bishop, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12064 · Cited by 124
Systems biology: personalized medicine for the future?
Chen, R., & Snyder, M. P. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.011 · Cited by 132
How Genetically Engineered Mouse Tumor Models Provide Insights Into Human Cancers
Politi, K. A., & Pao, W. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.8304 · Cited by 126
Estimation of rearrangement phylogeny for cancer genomesPreprint
Greenman, C., Pleasance, E., Newman, S., Yang, F., Fu, B., Nik‐Zainal, S., Jones, D., Lau, K. W., Carter, N., Edwards, P. A., et al. (2011) · Genome Research · doi:10.1101/gr.118414.110 · Cited by 122
Self-citationGenomic evidence for elevated mutation rates in highly expressed genes
Park, C., Qian, W., & Zhang, J. (2012) · EMBO Reports · doi:10.1038/embor.2012.165 · Cited by 123
Volatile fingerprints of cancer specific genetic mutations
Peled, N., Barash, O., Tisch, U., Ionescu, R., Broza, Y. Y., Ilouze, M., Mattei, J., Bunn, P. A., Hirsch, F. R., & Haick, H. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.01.008 · Cited by 121
Structural basis of CX-4945 binding to human protein kinase CK2
Ferguson, A. D., Sheth, P. R., Basso, A. D., Paliwal, S., Gray, K., Fischmann, T. O., & Le, H. V. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.11.019 · Cited by 121
An ensemble approach to accurately detect somatic mutations using SomaticSeq
Fang, L. T., Afshar, P. T., Chhibber, A., Mohiyuddin, M., Fan, Y., Mu, J. C., Gibeling, G., Barr, S. M., Asadi, N. B., Gerstein, M., et al. (2015) · Genome biology · doi:10.1186/s13059-015-0758-2 · Cited by 120
Guan, Y., Li, G.-R., Wang, R., Yi, Y., Yang, L. M., Jiang, D., Zhang, X., & Peng, Y. (2012) · 癌症：英文版 · doi:10.5732/cjc.012.10216 · Cited by 125
Wang, Q., Xia, J., Jia, P., Pao, W. J., & Zhao, Z. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs044 · Cited by 120
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
Griewank, K., Murali, R., Schilling, B., Scholz, S. L., Sucker, A., Song, M., Süßkind, D., Grabellus, F., Zimmer, L., Hillen, U., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.312 · Cited by 124
novoBreak: local assembly for breakpoint detection in cancer genomes
Chong, Z., Ruan, J., Gao, M., Zhou, W., Chen, T., Fan, X., Ding, L., Lee, A. Y., Boutros, P. C., Chen, J., et al. (2016) · Nature Methods · doi:10.1038/nmeth.4084 · Cited by 117
Shining Light on Skin Pigmentation: The Darker and the Brighter Side of Effects of UV Radiation†
Maddodi, N., Jayanthy, A., & Setaluri, V. (2012) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2012.01138.x · Cited by 124
Individual Genomes and Personalized Medicine: Life Diversity and Complexity
Katsios, C. G., & Roukos, D. H. (2010) · Personalized Medicine · doi:10.2217/pme.10.30 · Cited by 120
Loss of heterozygosity: what is it good for?
Ryland, G. L., Doyle, M., Goode, D. L., Boyle, S. E., Choong, D. Y. H., Rowley, S. M., Li, J., Australian Ovarian Cancer Study Group, Bowtell, D. D. L., Tothill, R. W., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0123-z · Cited by 121
Liu, L., De, S., & Michor, F. (2013) · Nature Communications · doi:10.1038/ncomms2502 · Cited by 123
Wee, E. J. H., Wang, Y., Tsao, S., & Trau, M. (2016) · Theranostics · doi:10.7150/thno.15871 · Cited by 113
Portrait of a cancer: mutational signature analyses for cancer diagnostics
Van Hoeck, A., Tjoonk, N. H., van Boxtel, R., & Cuppen, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5677-2 · Cited by 107
European Code against Cancer 4th Edition: Ultraviolet radiation and cancer
Greinert, R., de Vries, E., Erdmann, F., Espina, C., Auvinen, A. P., Kesminiene, A., & Schüz, J. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2014.12.014 · Cited by 126
Systematic discovery of complex insertions and deletions in human cancers
Ye, K., Wang, J., Jayasinghe, R. G., Lameijer, E.-W., McMichael, J. F., Ning, J., McLellan, M. D., Xie, M., Cao, S., Yellapantula, V. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.4002 · Cited by 118
Self-citationA new framework for analyzing organizational workplace religion and spirituality
Miller, D. W., & Ewest, T. G. (2015) · Journal of Management Spirituality & Religion · doi:10.1080/14766086.2015.1054864 · Cited by 117
Pan-cancer analysis of whole genomesPreprint
Campbell, P. J., Getz, G., Stuart, J. M., Korbel, J. O., & Stein, L. D. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/162784 · Cited by 117
Self-citationHuman genetics and genomics a decade after the release of the draft sequence of the human genome
Naidoo, N., Yudi Pawitan, Y., Soong, R., Cooper, D. N., & Ku, C. (2011) · Human Genomics · doi:10.1186/1479-7364-5-6-577 · Cited by 117
Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer
Romanish, M. T., Cohen, C., & Mager, D. L. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.005 · Cited by 115
Dendritic cells in cancer immunotherapy
Schuler, G. (2010) · European Journal of Immunology · doi:10.1002/eji.201040630 · Cited by 117
Advancing a clinically relevant perspective of the clonal nature of cancer
Ruiz, C. F., Lenkiewicz, E., Evers, L., Holley, T., Robeson, A., Kiefer, J., Demeure, M. J., Hollingsworth, M. A., Shen, M., Prunkard, D. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104009108 · Cited by 111
Mutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells
Rouhani, F. J., Nik‐Zainal, S., Wüster, A., Li, Y., Conte, N., Koike-Yusa, H., Kumasaka, N., Vallier, L., Yusa, K., & Bradley, A. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005932 · Cited by 113
Nair, N., Shoaib, M., & Sørensen, C. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071486 · Cited by 117
Griewank, K., Wiesner, T., Murali, R., Pischler, C., Müller, H., Koelsche, C., Möller, I., Franklin, C., Cosgarea, I., Sucker, A., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.146 · Cited by 111
Laikova, K. V., Oberemok, V. V., Krasnodubets, A. M., Gal’chinsky, N. V., Useinov, R. Z., Novikov, I. A., Temirova, Z. Z., Владимирович, Г. М., Shved, N. A., Kumeiko, V. V., et al. (2019) · Molecules · doi:10.3390/molecules24081516 · Cited by 119
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Newell, F., Johansson, P. A., Wilmott, J. S., Nones, K., Lakis, V., Pritchard, A. L., Lo, S., Rawson, R. V., Kazakoff, S. H., Colebatch, A. J., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0603 · Cited by 119
Tothill, R. W., Li, J., Mileshkin, L., Doig, K., Siganakis, T., Cowin, P. A., FELLOWES, A. P., Semple, T. J., Fox, S. B., Byron, K. A., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4251 · Cited by 108
Santarpia, L., Qi, Y., Stemke‐Hale, K., Wang, B., Young, E. J., Booser, D. J., Holmes, F. A., O’Shaughnessy, J., Hellerstedt, B. A., Pippen, J., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2035-3 · Cited by 109
Genome evolution during progression to breast cancerPreprint
Newburger, D. E., Kashef-Haghighi, D., Weng, Z., Salari, R., Sweeney, R. T., Brunner, A. L., Zhu, S., Guo, X., Varma, S., Troxell, M. L., et al. (2013) · Genome Research · doi:10.1101/gr.151670.112 · Cited by 108
Alexopoulos, L. G., Sáez-Rodríguez, J., Cosgrove, B. D., Lauffenburger, D. A., & Sorger, P. K. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.000406 · Cited by 113
Metadata
- Authors
- Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., Ye, K., Alipaz, J., Bauer, M. J., Beare, D., Butler, A., Carter, R. J., Chen, L., Cox, A. J., Edkins, S., Kokko-Gonzales, P. I., Gormley, N. A., Grocock, R. J., Haudenschild, C. D., Hims, M. M., James, T., Jia, M., Kingsbury, Z., Leroy, C., Marshall, J., Menzies, A., Mudie, L. J., Ning, Z., Royce, T., Schulz-Trieglaff, O. B., Spiridou, A., Stebbings, L. A., Szajkowski, L., Teague, J., Williamson, D., Chin, L., Ross, M. T., Campbell, P. J., Bentley, D. R., Futreal, P. A., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Illumina (United Kingdom) (GB)
- Leiden University Medical Center (NL)
- Illumina (United States) (US)
- Dana-Farber Cancer Institute (US)
- Institute of Cancer Research (GB)
- Corresponding author
- Futreal, P. Andrew
- Stratton, Michael R.
- ORCID
- Pleasance, Erin D.
- McBride, David J.
- Humphray, Sean J.
- Greenman, Chris D.
- Varela, Ignacio
- Lin, Meng-Lay
- Ye, Kai
- Bauer, Markus J.
- Chen, Lina
- Edkins, Sarah
- James, Terena
- Jia, Mingming
- Marshall, John
- Menzies, Andrew
- Ning, Zemin
- Spiridou, Anastassia
- Teague, Jon
- Ross, Mark T.
- Campbell, Peter J.
- Futreal, P. Andrew
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2009-12-16
- Volume
- 463
- Issue
- 7278
- Pages
- 191-196
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3145108
- OpenAlex
- W2150677022
- Cited by
- 1,696
- References
- 43
- Citations by year
- 2026: 23 · 2025: 47 · 2024: 43 · 2023: 49 · 2022: 50 · 2021: 83 · 2020: 76 · 2019: 87 · 2018: 69 · 2017: 94 · 2016: 121 · 2015: 116 · 2014: 144 · 2013: 166 · 2012: 189
- FWCI
- 58.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- Wellcome Trust (077012/Z/05/Z, 077012, 088340, 093867)
- Kay Kendall Leukaemia Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- somatic mutations, mutational signatures, melanoma, lymphoblastoid cell lines, DNA repair, small cell lung cancer, tobacco smoke carcinogens, driver mutations, passenger mutations, cancer genome evolution
- MeSH terms
- Adult, DNA Damage, DNA Mutational Analysis, DNA Repair, Humans, Male, Melanoma, Mutation, Neoplasms, Ultraviolet Rays, Genome, Human, Mutagenesis, Insertional, Sequence Deletion, Gene Dosage, Loss of Heterozygosity, Polymorphism, Single Nucleotide, MicroRNAs, Cell Line, Tumor, Genes, Neoplasm, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
